arrow
L

Laia Reverté

institut de recerca biomedica catalunya sud
H指数:16
被引数:1,033

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal evaluation of tumor-infiltrating lymphocyte scoring using automated region of interest registration in breast cancer

乳腺癌中应用自动化感兴趣区域注册进行肿瘤浸润淋巴细胞评分的纵向评估

2026-07-030
OAAI
Leveraging immune and clinicopathological profiles with machine learning to predict axillary lymph node metastasis in breast cancer patients

利用机器学习整合免疫和临床病理特征预测乳腺癌患者的腋窝淋巴结转移

2026-05-080
OAAI
Circulating pyruvate is a potent prognostic marker for critical COVID-19 outcomes

循环丙酮酸是关键新型冠状病毒肺炎结局的有效预后标志物

2022-09-1414
OAAI
Fetuin-A, inter-α-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes

胎蛋白A、间 α-胰蛋白酶抑制剂、谷氨酸和ChoE (18:0) 是区分轻度和危重冠状病毒疾病2019结局的关键生物标志物

2022-01-2410
OA
Epigenome-wide association study of COVID-19 severity with respiratory failure

新型冠状病毒肺炎严重程度与呼吸衰竭的表观基因组关联研究

2021-04-0191
OAAI
High circulating SDF-1 and MCP-1 levels and genetic variations in CXCL12, CCL2 and CCR5: Prognostic signature of immune recovery status in treated HIV-positive patients
2020-12-0117
OAAI